A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.
BP45361
Phase 1 other active
Quick answer
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease. for Parkinson’s Disease is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Parkinson’s Disease
- Phase
- Phase 1
- Modality
- other
- Status
- active